600873 梅花生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额4,711,1604,626,7155,228,9375,654,9543,734,332
投资活动产生之现金流量净额(3,574,682)(2,648,959)(1,509,146)(1,738,222)(386,834)
筹资活动产生之现金流量净额(1,041,147)(2,738,052)(3,108,097)(3,093,970)(1,570,882)
汇率变动对现金及现金等价物的影响25,528111,54140,12151,055(16,287)
现金及现金等价物净增加/(减少)120,859(648,755)651,815873,8171,760,328
期初现金及现金等价物余额4,131,8604,780,6144,128,8003,254,9831,494,654
期末现金及现金等价物余额4,252,7184,131,8604,780,6144,128,8003,254,983